1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pralatrexate in patients with relapsed/refractory peripheral T-cell lymphoma (PTCL): Relationship between response and survival
    Meeting Abstract

    Shustov, A. R.; Pro, B.; Horwitz, S. M.; Jacobsen, E. D.; Boyd, A.; Fruchtman, S. M.; O'Connor, O.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Anti-insulin-like growth factor-1 receptor (IGF-IR) monoclonal antibody cixutumumab plus mammalian target of rapamycin (mTOR) inhibitor temsirolimus in metastatic castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Rathkopf, D. E.; Danila, D. C.; Chudow, J. J.; Morris, M. J.; Slovin, S. F.; Fine, S.; Fox, J. J.; Larson, S. M.; Rosen, N.; Scher, H. I.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • In vitro analysis of suicide gene expression and function in human T lymphocytes transduced to express a tumour-targeted chimeric antigen receptor
    Meeting Abstract

    Park, J. H.; Yeh, R.; Riviere, I.; Sadelain, M.; Brentjens, R. J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Prognostic implications of mutations in the epidermal growth factor receptor (EGFR) and KRAS among never-smokers with adenocarcinoma of the lung
    Meeting Abstract

    Paik, P. K.; Johnson, M. L.; D'Angelo, S. P.; Sima, C.; Janjigian, Y. Y.; Riely, G. J.; Kris, M. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • EGFR mutations in men and cigarette smokers with lung adenocarcinoma
    Meeting Abstract

    Pietanza, M.; D'Angelo, S. P.; Johnson, M. L.; Paik, P. K.; Riely, G. J.; Miller, V. A.; Zakowski, M. F.; Rusch, V. W.; Ladanyi, M.; Kris, M. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • CA125 response to bevacizumab in recurrent ovarian cancer
    Meeting Abstract

    O'Cearbhaill, R. E.; Zhou, Q.; Iasonos, A.; Diaz, J. P.; Tew, W. P.; Hensley, M. L.; O'Flaherty, C.; Aghajanian, C.; Spriggs, D. R.; Sabbatini, P.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A phase I/II trial of clofarabine in patients with relapsed T-cell or NK-cell lymphomas
    Meeting Abstract

    Mulford, D. A.; Pohiman, B. L.; Hamlin, P. A.; Young, F.; Pamer, E.; Horwitz, S. M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Reactivation of chronic hepatitis B virus in cancer patients receiving immunosuppression: The case for screening
    Meeting Abstract

    Mendelsohn, R. B.; Nagula, S.; Taur, Y.; Kamboj, M.; Sepkowitz, K.; Zelenetz, A. D.; Ludwig, E.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Phase III intergroup study of lenalidomide versus placebo maintenance therapy following single autologous stem cell transplant (ASCT) for multiple myeloma (MM): CALGB 100104
    Meeting Abstract

    McCarthy, P. L.; Owzar, K.; Anderson, K. C.; Hofmeister, C. C.; Hassoun, H.; Hurd, D. D.; Stadtmauer, E. A.; Giralt, S.; Hars, V.; Linker, C. A.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Prevalence of hepatitis B surface antigen and hepatitis B core antibody in a population initiating immunosuppressive therapy
    Meeting Abstract

    Ludwig, E.; Mendelsohn, R. B.; Taur, Y.; Kamboj, M.; Nagula, S.; Sepkowitz, K.; Zelenetz, A. D.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save